Polymorphonuclear leucocyte respiratory burst activity correlates with serum zinc level in type 2 diabetic patients

B Larijani1, P Shooshtarizadeh, N Mosaffa

  • 1Endocrinology and Metabolism Research Centre, Tehran University of Medical Sciences, Doctor Shariati Hospital, Iran. emrc@sina.tums.ac.ir

Insights

Type 2 diabetes patients with foot ulcers show lower serum zinc levels and impaired polymorphonuclear (PMN) respiratory burst activity, increasing infection risk. Zinc status impacts PMN function in diabetes.

Area of Science:

  • Immunology
  • Endocrinology
  • Nutritional Science

Background:

  • Diabetes mellitus (DM) is linked to increased infection susceptibility due to impaired phagocyte function.
  • Polymorphonuclear (PMN) leucocyte superoxide generation and zinc status are critical factors in DM pathogenesis.

Purpose of the Study:

  • To investigate the association between serum zinc levels and PMN respiratory burst activity in type 2 DM patients.
  • To compare these parameters in diabetic patients with and without foot ulcers.

Main Methods:

  • Evaluated respiratory burst activity using the nitro blue tetrazolium (NBT) reduction test at baseline and stimulated states.
  • Measured serum zinc levels via atomic absorption spectrophotometry.
  • Studied 39 type 2 DM patients (19 with foot ulcers) and 20 healthy controls.

Main Results:

  • PMNs from diabetic patients with foot ulcers showed slightly higher baseline activity but significantly lower stimulated NBT index.
  • Mean serum zinc levels were significantly lower in diabetic patients with foot ulcers.
  • Found a negative baseline correlation and a positive stimulated correlation between serum zinc and NBT index in patients with foot ulcers.

Conclusions:

  • Diabetic patients, especially those with foot ulcers, exhibit altered PMN respiratory burst activity and lower serum zinc.
  • These alterations may contribute to increased infection risk in diabetic patients.
  • Serum zinc levels correlate with PMN function, suggesting a potential therapeutic target.